Protagenic Therapeutics, Inc.\new (PTIX) Net Cash Flow (2013 - 2026)
Protagenic Therapeutics, Inc.\new (PTIX) reported Net Cash Flow of -$944,298 for fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with $4.2 million a year earlier.
Powered by 
Analysis
Protagenic Therapeutics, Inc.\new (PTIX) Net Cash Flow (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Protagenic Therapeutics, Inc.\new's Net Cash Flow came in at -$3.45 million; for FY2026 (ended Mar 31, 2026), it was $1.7 million.
- By fiscal year, Net Cash Flow came in at $40,357 in FY2025, $549,909 in FY2024 (-48.7%), $1.07 million in FY2023 and -$396,840 in FY2022.
- Five-year quarterly Net Cash Flow spans a low of -$1.41 million in fiscal Q2 2026 and a high of $4.2 million in fiscal Q1 2026.
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at -$581,662 (Q4 2026), -$509,669 (Q3 2026) and -$1.41 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 3.72 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | -3.52 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | -2.82 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 1.53 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 757.00 Mn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | -3.94 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 1.95 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -4.43 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | -722.00 Mn |
| 10 | Protagenic Therapeutics, Inc.\new | 1.36 Mn | 1.36 Mn | - | -944,298.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -944,298.00 |
| Mar 31, 2026 | -581,662.00 |
| Dec 31, 2025 | -509,669.00 |
| Sep 30, 2025 | -1.41 Mn |
| Jun 30, 2025 | 4.20 Mn |
| Mar 31, 2025 | -965,498.00 |
| Dec 31, 2024 | 782,265.00 |
| Sep 30, 2024 | 131,298.00 |
| Jun 30, 2024 | 48,120.00 |
| Mar 31, 2024 | -456,305.00 |
| Dec 31, 2023 | 1.13 Mn |
| Sep 30, 2023 | -65,043.00 |
| Jun 30, 2023 | 80,273.00 |
| Mar 31, 2023 | -77,165.00 |
| Dec 31, 2022 | -19,170.00 |
| Sep 30, 2022 | -177,704.00 |
| Jun 30, 2022 | -140,164.00 |
| Mar 31, 2022 | -59,802.00 |
| Dec 31, 2021 | 80,857.00 |
| Sep 30, 2021 | -1.08 Mn |
API Access
Protagenic Therapeutics, Inc.\new Net Cash Flow API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-cash-flow&ticker=PTIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-cash-flow", "ticker": "PTIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-cash-flow&ticker=PTIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();